Skip to main navigation Skip to search Skip to main content

The prognostic value of KRAS mutation in locally advanced rectal cancer

  • Palash Asawa
  • , Veli Bakalov
  • , Pragnan Kancharla
  • , Stephen Abel
  • , Zena Chahine
  • , Dulabh K. Monga
  • , Alexander V. Kirichenko
  • , Rodney E. Wegner

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

Background: The prognostic value of the KRAS proto-oncogene mutation in colorectal cancer has been debated. Herein, we analyzed the National Cancer Database (NCDB) to assess the role of KRAS mutation as a prognostic marker in patients with locally advanced rectal cancer (LARC). Methods: We identified LARC patients treated with neoadjuvant chemoradiation from 2004–2015 excluding those with stage I/IV disease and unknown KRAS status. Multivariable logistic regression identified variables associated with KRAS positivity. Propensity adjusted univariable and multivariable analyses identified predictors of survival. Results: Of the 784 eligible patients, 506 were KRAS-negative (KRAS −) and 278 were KRAS-positive (KRAS +). Median survival was 63.6 months and 76.3 months for KRAS + and KRAS − patients respectively, with propensity adjusted 3 and 5-year survival of 79.9% vs. 83.6% and 56.7% vs. 61.9% respectively (HR 1.56, p 1.074–2.272). Male sex, no insurance, and KRAS + disease were associated with poorer survival on unadjusted and propensity adjusted multivariable analyses. Conclusions: Our analysis of KRAS + LARC suggest that KRAS + disease is associated with poorer overall survival. Given the inherent limitations of retrospective data, prospective validation is warranted.

Original languageEnglish
Pages (from-to)1199-1207
Number of pages9
JournalInternational Journal of Colorectal Disease
Volume37
Issue number5
DOIs
StatePublished - May 2022

Bibliographical note

Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Colorectal cancers
  • Gene mutations
  • KRAS mutation
  • Locally advanced rectal cancer
  • Prognostic value

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint

Dive into the research topics of 'The prognostic value of KRAS mutation in locally advanced rectal cancer'. Together they form a unique fingerprint.

Cite this